Moreover, CUX1 could behave as an oncogene that stimulated the malignant phenotype (EMT) by activating the Wnt/β-catenin signaling pathway in glioma cells and as a potential target for the development of anti-glioma drugs. The gene discussed is CUX1; the disease is central nervous system cancer.